Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack A Roth

Showing results (141-150 of 352) with videos related to

Pageof 36
Sort By:
Molecular Cancer Research : MCR|August 13, 2009
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1Liqin Du, Jeoffrey J Schageman, Maria C Subauste, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancerLudmila Prudkin, Carmen Behrens, Diane D Liu, et al.
The Annals of Thoracic Surgery|July 24, 2012
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapyArya Amini, Arlene M Correa, Ritsuko Komaki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancerJoe Y Chang, Peter A Balter, Lei Dong, et al.
Cancer|June 30, 2011
A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumorsDaniel R Gomez, James D Cox, Jack A Roth, et al.
Clinical Pharmacology and Therapeutics|September 12, 2017
Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1Liren Zhang, Jing Lin, Yuanqing Ye, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiationZhongxing Liao, Hongji Liu, Stephen G Swisher, et al.
Oncotarget|June 22, 2017
Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeuticsEmanuela Gentile, Taro Oba, Jing Lin, et al.
Cancer Research|June 19, 2007
A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancerAnissa N Elayadi, Kausar N Samli, Ludmila Prudkin, et al.
Cancer|February 19, 2005
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationLucian R Chirieac, Stephen G Swisher, Jaffer A Ajani, et al.
Pageof 36

Showing results (141-150 of 352) with videos related to

Sort By:
Pageof 36
Molecular Cancer Research : MCR|August 13, 2009
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1Liqin Du, Jeoffrey J Schageman, Maria C Subauste, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancerLudmila Prudkin, Carmen Behrens, Diane D Liu, et al.
The Annals of Thoracic Surgery|July 24, 2012
The role of consolidation therapy for stage III non-small cell lung cancer with persistent N2 disease after induction chemotherapyArya Amini, Arlene M Correa, Ritsuko Komaki, et al.
International Journal of Radiation Oncology, Biology, Physics|October 29, 2008
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancerJoe Y Chang, Peter A Balter, Lei Dong, et al.
Cancer|June 30, 2011
A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumorsDaniel R Gomez, James D Cox, Jack A Roth, et al.
Clinical Pharmacology and Therapeutics|September 12, 2017
Serum MicroRNA-150 Predicts Prognosis for Early-Stage Non-Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1Liren Zhang, Jing Lin, Yuanqing Ye, et al.
International Journal of Radiation Oncology, Biology, Physics|October 26, 2005
Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiationZhongxing Liao, Hongji Liu, Stephen G Swisher, et al.
Oncotarget|June 22, 2017
Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeuticsEmanuela Gentile, Taro Oba, Jing Lin, et al.
Cancer Research|June 19, 2007
A peptide selected by biopanning identifies the integrin alphavbeta6 as a prognostic biomarker for nonsmall cell lung cancerAnissa N Elayadi, Kausar N Samli, Ludmila Prudkin, et al.
Cancer|February 19, 2005
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiationLucian R Chirieac, Stephen G Swisher, Jaffer A Ajani, et al.
Pageof 36